- JP-listed companies
- Daito Pharmaceutical Co., Ltd.
- Income statement
Daito Pharmaceutical Co., Ltd.【JP:4577】Income statement
Market cap
¥41B
P/E ratio
17.8x
| 2012/05 | 2013/05 | 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Revenue | 27,151 | 28,956 | 31,196 | 34,059 | 36,371 | 37,984 | 39,876 | 41,135 | 44,991 | 48,715 | 43,464 | 45,101 | 46,895 | 50,643 |
| Cost of revenue | - | - | - | 26,990 | 29,104 | 30,232 | 31,765 | 32,463 | 35,513 | 37,917 | 32,005 | 34,770 | 37,056 | 42,005 |
| Gross profit | - | - | - | 7,068 | 7,266 | 7,752 | 8,111 | 8,671 | 9,479 | 10,798 | 11,458 | 10,331 | 9,839 | 8,637 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 3,519 | 3,556 | 3,832 | 4,161 | 4,547 | 5,357 | 5,909 | 6,553 | 5,207 | 3,894 | 2,619 |
| Operating expenses | - | - | - | 3,553 | 3,671 | 3,909 | 3,957 | 4,124 | 4,127 | 4,883 | 4,905 | 5,123 | 5,945 | 6,017 |
| Income before tax | 2,572 | 2,541 | 2,921 | 3,453 | 3,714 | 3,879 | 4,244 | 4,642 | 5,463 | 6,068 | 6,729 | 5,169 | 3,923 | 2,705 |
| Provision for income taxes | - | - | - | 1,136 | 879 | 1,258 | 1,251 | 1,122 | 1,670 | 1,717 | 2,092 | 1,549 | 1,040 | 1,192 |
| Net income | 1,149 | 1,511 | 1,560 | 2,246 | 2,566 | 2,656 | 3,042 | 3,513 | 3,945 | 4,246 | 4,668 | 3,600 | 3,295 | 1,908 |
| Earnings per share | 155.1 | 194.13 | 166.58 | 183.51 | 205.07 | 212.26 | 243.08 | 280.73 | 309.66 | 311.02 | 335.41 | 250.39 | 210 | 62.74 |
| Diluted EPS | - | - | - | - | - | - | - | - | 307.44 | - | - | 250.17 | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Dividend per share | 30 | 30 | 30 | 30 | 30 | 33 | 33 | 38 | 46 | 46 | 60 | 60 | 60 | 70 |